 |
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
|
|
|
|
|
|
|
Plasminogen activator
|
PDB id
|
|
|
|
1tpk
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
|
PDB id:
|
 |
|
 |
| Name: |
 |
Plasminogen activator
|
 |
|
Title:
|
 |
Crystal structure of the kringle-2 domain of tissue plasmino activator at 2.4-angstroms resolution
|
|
Structure:
|
 |
Tissue plasminogen activator. Chain: a, b, c. Engineered: yes
|
|
Source:
|
 |
Homo sapiens. Human. Organism_taxid: 9606
|
|
Resolution:
|
 |
|
|
Authors:
|
 |
A.M.De Vos,M.H.Ultsch,R.F.Kelley,K.Padmanabhan,A.Tulinsky, M.L.Westbrook,A.A.Kossiakoff
|
Key ref:
|
 |
A.M.de Vos
et al.
(1992).
Crystal structure of the kringle 2 domain of tissue plasminogen activator at 2.4-A resolution.
Biochemistry,
31,
270-279.
PubMed id:
DOI:
|
 |
|
Date:
|
 |
|
24-Sep-91
|
Release date:
|
15-Jul-92
|
|
|
|
|
|
PROCHECK
|
|
|
|
|
Headers
|
 |
|
|
References
|
|
|
|
|
|
|
|
|
|
P00750
(TPA_HUMAN) -
Tissue-type plasminogen activator
|
|
|
|
Seq: Struc:
|
 |
 |
 |
562 a.a.
88 a.a.
|
|
|
|
|
|
|
 |
 |
|
|
Key: |
 |
PfamA domain |
 |
 |
 |
Secondary structure |
 |
 |
CATH domain |
 |
|
|
|
|
 |
|
|
 |
 |
 |
 |
Enzyme class:
|
 |
E.C.3.4.21.68
- T-plasminogen activator.
|
|
 |
 |
 |
 |
 |
Reaction:
|
 |
Specific cleavage of Arg-|-Val bond in plasminogen to form plasmin.
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
DOI no:
|
Biochemistry
31:270-279
(1992)
|
|
PubMed id:
|
|
|
|
|
| |
|
Crystal structure of the kringle 2 domain of tissue plasminogen activator at 2.4-A resolution.
|
|
A.M.de Vos,
M.H.Ultsch,
R.F.Kelley,
K.Padmanabhan,
A.Tulinsky,
M.L.Westbrook,
A.A.Kossiakoff.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
The crystal structure of the kringle 2 domain of tissue plasminogen activator
was determined and refined at a resolution of 2.43 A. The overall fold of the
molecule is similar to that of prothrombin kringle 1 and plasminogen kringle 4;
however, there are differences in the lysine binding pocket, and two looping
regions, which include insertions in kringle 2, take on very different
conformations. Based on a comparison of the overall structural homology between
kringle 2 and kringle 4, a new sequence alignment for kringle domains is
proposed that results in a division of kringle domains into two groups,
consistent with their proposed evolutionary relation. The crystal structure
shows a strong interaction between a lysine residue of one molecule and the
lysine/fibrin binding pocket of a noncrystallographically related neighbor. This
interaction represents a good model of a bound protein ligand and is the first
such ligand that has been observed in a kringle binding pocket. The structure
shows an intricate network of interactions both among the binding pocket
residues and between binding pocket residues and the lysine ligand. A lysine
side chain is identified as the positively charged group positioned to interact
with the carboxylate of lysine and lysine analogue ligands. In addition, a
chloride ion is located in the kringle-kringle interface and contributes to the
observed interaction between kringle molecules.
|
|
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
J.Schaller,
and
S.S.Gerber
(2011).
The plasmin-antiplasmin system: structural and functional aspects.
|
| |
Cell Mol Life Sci, 68,
785-801.
|
 |
|
|
|
|
 |
J.Stie,
G.Bruni,
and
D.Fox
(2009).
Surface-associated plasminogen binding of Cryptococcus neoformans promotes extracellular matrix invasion.
|
| |
PLoS One, 4,
e5780.
|
 |
|
|
|
|
 |
G.Epple,
W.D.Schleuning,
G.Kettelgerdes,
E.Kottgen,
R.Gessner,
and
M.Praus
(2004).
Prion protein stimulates tissue-type plasminogen activator-mediated plasmin generation via a lysine-binding site on kringle 2.
|
| |
J Thromb Haemost, 2,
962-968.
|
 |
|
|
|
|
 |
J.H.Geiger,
and
S.E.Cnudde
(2004).
What the structure of angiostatin may tell us about its mechanism of action.
|
| |
J Thromb Haemost, 2,
23-34.
|
 |
|
|
|
|
 |
K.S.Kim,
Y.K.Hong,
Y.A.Joe,
Y.Lee,
J.Y.Shin,
H.E.Park,
I.H.Lee,
S.Y.Lee,
D.K.Kang,
S.I.Chang,
and
S.I.Chung
(2003).
Anti-angiogenic activity of the recombinant kringle domain of urokinase and its specific entry into endothelial cells.
|
| |
J Biol Chem, 278,
11449-11456.
|
 |
|
|
|
|
 |
Y.J.Park,
J.F.Liang,
H.Song,
Y.T.Li,
S.Naik,
and
V.C.Yang
(2003).
ATTEMPTS: a heparin/protamine-based triggered release system for the delivery of enzyme drugs without associated side-effects.
|
| |
Adv Drug Deliv Rev, 55,
251-265.
|
 |
|
|
|
|
 |
M.Gehrmann,
K.Briknarová,
L.Bányai,
L.Patthy,
and
M.Llinás
(2002).
The col-1 module of human matrix metalloproteinase-2 (MMP-2): structural/functional relatedness between gelatin-binding fibronectin type II modules and lysine-binding kringle domains.
|
| |
Biol Chem, 383,
137-148.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
M.T.Stubbs,
M.Renatus,
and
W.Bode
(1998).
An active zymogen: unravelling the mystery of tissue-type plasminogen activator.
|
| |
Biol Chem, 379,
95.
|
 |
|
|
|
|
 |
M.Ultsch,
N.A.Lokker,
P.J.Godowski,
and
A.M.de Vos
(1998).
Crystal structure of the NK1 fragment of human hepatocyte growth factor at 2.0 A resolution.
|
| |
Structure, 6,
1383-1393.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
S.S.An,
D.N.Marti,
C.Carreño,
F.Albericio,
J.Schaller,
and
M.Llinas
(1998).
Structural/functional properties of the Glu1-HSer57 N-terminal fragment of human plasminogen: conformational characterization and interaction with kringle domains.
|
| |
Protein Sci, 7,
1947-1959.
|
 |
|
|
|
|
 |
T.Huby,
J.Chapman,
and
J.Thillet
(1997).
Pathophysiological implication of the structural domains of lipoprotein(a).
|
| |
Atherosclerosis, 133,
1-6.
|
 |
|
|
|
|
 |
W.Bode,
and
M.Renatus
(1997).
Tissue-type plasminogen activator: variants and crystal/solution structures demarcate structural determinants of function.
|
| |
Curr Opin Struct Biol, 7,
865-872.
|
 |
|
|
|
|
 |
A.A.Higazi,
T.Ganz,
K.Kariko,
and
D.B.Cines
(1996).
Defensin modulates tissue-type plasminogen activator and plasminogen binding to fibrin and endothelial cells.
|
| |
J Biol Chem, 271,
17650-17655.
|
 |
|
|
|
|
 |
J.Guevara,
N.V.Valentinova,
O.Garcia,
A.M.Gotto,
C.Y.Yang,
S.Legal,
J.Gaubatz,
and
J.T.Sparrow
(1996).
Interaction of apolipoprotein[a] with apolipoproteinB-100 Cys3734 region in lipoprotein[a] is confirmed immunochemically.
|
| |
J Protein Chem, 15,
17-25.
|
 |
|
|
|
|
 |
O.Zhao,
and
I.M.Kovach
(1996).
Reversible modification of tissue-type plasminogen activator by methylphosphonate esters.
|
| |
Bioorg Med Chem, 4,
523-529.
|
 |
|
|
|
|
 |
P.Bork,
A.K.Downing,
B.Kieffer,
and
I.D.Campbell
(1996).
Structure and distribution of modules in extracellular proteins.
|
| |
Q Rev Biophys, 29,
119-167.
|
 |
|
|
|
|
 |
A.Ernst,
M.Helmhold,
C.Brunner,
A.Pethö-Schramm,
V.W.Armstrong,
and
H.J.Müller
(1995).
Identification of two functionally distinct lysine-binding sites in kringle 37 and in kringles 32-36 of human apolipoprotein(a).
|
| |
J Biol Chem, 270,
6227-6234.
|
 |
|
|
|
|
 |
A.H.Bakker,
E.J.Weening-Verhoeff,
and
J.H.Verheijen
(1995).
The role of the lysyl binding site of tissue-type plasminogen activator in the interaction with a forming fibrin clot.
|
| |
J Biol Chem, 270,
12355-12360.
|
 |
|
|
|
|
 |
K.Mori,
R.A.Dwek,
A.K.Downing,
G.Opdenakker,
and
P.M.Rudd
(1995).
The activation of type 1 and type 2 plasminogen by type I and type II tissue plasminogen activator.
|
| |
J Biol Chem, 270,
3261-3267.
|
 |
|
|
|
|
 |
P.M.Rudd,
R.J.Woods,
M.R.Wormald,
G.Opdenakker,
A.K.Downing,
I.D.Campbell,
and
R.A.Dwek
(1995).
The effects of variable glycosylation on the functional activities of ribonuclease, plasminogen and tissue plasminogen activator.
|
| |
Biochim Biophys Acta, 1248,
1.
|
 |
|
|
|
|
 |
R.C.Ladner
(1995).
Constrained peptides as binding entities.
|
| |
Trends Biotechnol, 13,
426-430.
|
 |
|
|
|
|
 |
B.A.Keyt,
N.F.Paoni,
C.J.Refino,
L.Berleau,
H.Nguyen,
A.Chow,
J.Lai,
L.Peña,
C.Pater,
and
J.Ogez
(1994).
A faster-acting and more potent form of tissue plasminogen activator.
|
| |
Proc Natl Acad Sci U S A, 91,
3670-3674.
|
 |
|
|
|
|
 |
D.Marti,
J.Schaller,
B.Ochensberger,
and
E.E.Rickli
(1994).
Expression, purification and characterization of the recombinant kringle 2 and kringle 3 domains of human plasminogen and analysis of their binding affinity for omega-aminocarboxylic acids.
|
| |
Eur J Biochem, 219,
455-462.
|
 |
|
|
|
|
 |
I.D.Campbell,
and
A.K.Downing
(1994).
Building protein structure and function from modular units.
|
| |
Trends Biotechnol, 12,
168-172.
|
 |
|
|
|
|
 |
L.E.Donate,
E.Gherardi,
N.Srinivasan,
R.Sowdhamini,
S.Aparicio,
and
T.L.Blundell
(1994).
Molecular evolution and domain structure of plasminogen-related growth factors (HGF/SF and HGF1/MSP).
|
| |
Protein Sci, 3,
2378-2394.
|
 |
|
|
|
|
 |
M.R.Rejante,
and
M.Llinás
(1994).
1H-NMR assignments and secondary structure of human plasminogen kringle 1.
|
| |
Eur J Biochem, 221,
927-937.
|
 |
|
|
|
|
 |
M.R.Rejante,
and
M.Llinás
(1994).
Solution structure of the epsilon-aminohexanoic acid complex of human plasminogen kringle 1.
|
| |
Eur J Biochem, 221,
939-949.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
C.A.Orengo,
and
J.M.Thornton
(1993).
Alpha plus beta folds revisited: some favoured motifs.
|
| |
Structure, 1,
105-120.
|
 |
|
|
|
|
 |
J.Guevara,
J.Spurlino,
A.Y.Jan,
C.Y.Yang,
A.Tulinsky,
B.V.Prasad,
J.W.Gaubatz,
and
J.D.Morrisett
(1993).
Proposed mechanisms for binding of apo[a] kringle type 9 to apo B-100 in human lipoprotein[a].
|
| |
Biophys J, 64,
686-700.
|
 |
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
Where a reference describes a PDB structure, the PDB
code is
shown on the right.
|
|